Jazz Pharma Bets $175 Million on This Massachusetts Biotech's Antibody-Drug Program Post author:Sam Post published:August 28, 2017 Post category:BioPharma August 29, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like A Peek Behind the Curtain of the Ariad-Takeda Deal January 19, 2017 Bleeding Money, s NantHealth Restructures and Lays Off 300 August 10, 2017 Why Pfizer Could and Should Scoop Up Celgene in 2018 December 4, 2017
